No quick cure for Amryt Pharma investors

cathal-friel

IN A complete shift of gear, Cathal Friel has turned Fastnet Oil & Gas into Amryt Pharmaceuticals. At first sight, moving from a failing oil and gas business into a pharmaceutical operation specialising in ‘orphan’ drug development seems simply bizarre. Friel, who is both the chairman and largest shareholder in Fastnet, with a 12% stake,… Read more »

I'm a Subscriber